Home/Filings/4/0001181431-10-041173
4//SEC Filing

DUFFEY SAMUEL S 4

Accession 0001181431-10-041173

CIK 0001310094other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 3:48 PM ET

Size

9.1 KB

Accession

0001181431-10-041173

Insider Transaction Report

Form 4
Period: 2008-11-18
DUFFEY SAMUEL S
PRESIDENT AND GENERAL COUNSEL
Transactions
  • Award

    Stock Option (Right to Buy)

    2008-11-13+2,000,0002,000,000 total
    Exercise: $0.18Exp: 2018-11-13Common Stock (2,000,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2010-02-12+4,250,0004,250,000 total
    Exercise: $0.44Exp: 2020-02-12Common Stock (4,250,000 underlying)
Footnotes (5)
  • [F1]Exercise price is 100% of fair market value on date of grant.
  • [F2]Options terminate 10 years from grant date, or 90 days after the non-employee director ceases to be a director for any reason, other than death, disability or retirement.
  • [F3]Stock options acquired pursuant to the Issuer's plan of compensation to Employees
  • [F4]The options shall vest in three equal tranches: (a) one-third on the date of confirmation of the Issuer's Bankruptcy Plan of Reorganization; (b) one-third on the 90th after the date of confirmation of the Issuer's Bankruptcy Plan of Reorganization; and (c) one-third on the 180th after the date of confirmation of the Issuer's Bankruptcy Plan of Reorganization. Shares underlying the options are restricted as to resale until the 12-month anniversary of the effective date of the Issuer's Bankruptcy Plan of Reorganization.
  • [F5]The option shall become 100% vested upon effective date of the Issuer's Bankruptcy Plan of Reorganization and the first to occur of a) six (6) months following the closing of a capital raise by the Issuer's with gross proceeds of a minimum of $5.0 million; or b) two (2) years from the effective date of the Issuer's Bankruptcy Plan. Shares underlying the options are restricted as to resale until the 12-month anniversary of the effective date of the Issuer's Bankruptcy Plan of Reorganization.

Documents

1 file

Issuer

ACCENTIA BIOPHARMACEUTICALS INC

CIK 0001310094

Entity typeother

Related Parties

1
  • filerCIK 0001255259

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 3:48 PM ET
Size
9.1 KB